Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.
Over the years Alzheimer’s patients and their families have seen more than one hundred twenty drugs that were developed for the treatment of Alzheimer's have failed. For a while,…
Continue ReadingAfter 120 Drug Failures, Can this be the Drug to Slow Alzheimer’s Progression?
A guest speaker at the 2019 Rare Disease Forum recently held at the North Carolina Biotechnology Center acknowledged that screening is necessary to justify the need for a particular…
CNN recently covered a story in the publication Nature about a paper explaining base editing (or prime editing). The researchers who created the technology set forth the process of using base…
Continue ReadingNew Prime Editing Has The Potential to Search and Replace up to 89% of Genetic Defects
According to a recent article in Horizon, the World Health Organization estimates that every one couple out of ten is dealing with fertility issues. The long-held assumption has been…
Continue ReadingAs More Women Delay Pregnancy, Physiological Changes Increase
A recent article in Medical Life Science News reports that a recent study has discovered a new mechanism that interacts with an immune cell receptor called Mincle. This receptor regulates…
Continue ReadingStudy Results in a New Mechanism to Treat Ulcerative Colitis and Crohn’s Disease
A recent article in the Science Daily reports on a study that demonstrated in detail how the human immune system located in the brain is altered during certain diseases such…
Continue ReadingScientists Have Created an Entirely New Map of the Brain’s Own Immune System in Humans and Mice
Scientists believe that “it is in our DNA.” According to a recent article in EurekAlert, a five-year study formulated through Open Targets together with the Sanger Institute and their…
Continue ReadingThe Open Targets Initiative Brings Scientists Closer to Identifying the Cause of Autoimmune Diseases
Lately, there have been many newsworthy articles about Novartis and Zolgensma (onasemnogene abeparvovec-xioi). In May 2019 the FDA approved Zolgensma, a one-time treatment for the most severe form of…
Continue ReadingZolgensma for Spinal Muscular Atrophy: From Approval to Present Day
Jessica Walton described the staff at Queen Elizabeth Hospital in King’s Lynn as being in “a bit of a panic” when they thought that she was having a stroke.…
Continue ReadingIdiopathic Intracranial Hypertension: Symptoms are Common but the Disease is Rare
A recent article in Forbes highlights a study on diagnostic performance published in The Lancet Digital Health. The study represents the first review to compare the diagnostic accuracy of deep…
Continue ReadingThe Next Frontier for Artificial Intelligence: Diagnosing Disease and Designing Drugs
Mila Makovec began her life as a normal, healthy infant, and according to a recent article in Science Magazine, she continued along this path until reaching the age of…
Continue ReadingPersonalized Medicine: A Drug Tailored for a Six Year Old With Batten Disease May Serve as a Template for Similar Rare Disorders
Supplies of a Critical Bladder Cancer Drug are Dwindling Bob Field, a 72-year-old New York banking executive, received a call from his urologist’s office canceling his next appointment. According to…
Continue ReadingSupplies of a Critical Bladder Cancer Drug are Dwindling
According to a recent article published by the University of California San Francisco, Pelizaeus-Merzbacher disease (PMD) is a rare neurological disease affecting young boys. PMD fatalities may occur before the child…
Continue ReadingFound: Pelizaeus-Merzbacher Disease, the Cause, and a Potential Cure
Physician and investigator John Wood, MD, Ph.D. of Childrens Hospital of Los Angeles specializes in studying the challenges facing SCD patients. He has currently focused his attention on how oxygen delivery…
Continue ReadingStudies Reveal How Blood Flow and Oxygen Delivery Are Affected by Sickle Cell Disease (SCD)
According to a recent article in SMA News Today, risdiplam (formerly RG7916) is in ongoing studies of patients with spinal muscular atrophy (SMA). The drug is an investigational medicine developed by Genentech…
Continue ReadingClinical Trials Show Promising Results for Risdiplam in Treatment of Spinal Muscular Atrophy Types 1, 2, and 3
Waukesha Wisconsin Police Captain Dan Baumann recently held a news conference that was described in an article published in Scientific American. Captain Baumann said that parents of a teenage boy showed…
Continue ReadingICYMI: Doctors Searching for the Cause of a Deadly Lung Disease Warn: Do Not Vape
FierceBiotech recently reported that Helixmith Co., based in Korea and previously known as ViroMed, coordinated a Phase 3 clinical trial involving five hundred diabetic peripheral neuropathy (DPN) patients. The…
Continue ReadingThe Phase 3 Trial in Diabetic Peripheral Neuropathy May Have Failed Due to a Critical Mistake
Pamela Smith, age 67, had run out of options when her melanoma metastasized and became inoperable. According to a recent article in MedicalXpress, in January 2014, Pamela joined the…
Continue ReadingMetastatic Melanoma was Untreatable but Two Drugs Have Changed the Landscape
The Providence Journal recently published an article by Brittany Ricci, a student at Brown University’s Alpert Medical School, detailing her year-long struggle to receive the treatment her doctor had prescribed…
Continue ReadingStep Therapy Supposedly Minimizes Risk, but for Brittany it Caused Severe Complications
A new treatment was recently tested for blastic plasmacytoid dendritic cell neoplasm (BPDCN). A recent article in MD Anderson News points out that in the U.S., five hundred to…
Continue ReadingThis Treatment for BPDCN is Having an Impact on the Lives of Patients
Richard Engel’s son Henry, age 4, has been diagnosed with Rett syndrome, a thus far incurable genetic neurological disease. Engel is chief foreign war correspondent at NBC and has…
Continue ReadingChief Foreign War Correspondent at NBC News Gives Account of His 4-Year-Old Son With Rett Syndrome
A molecular biologist, Dr. Daria Julkowska, coordinates an international consortium in Paris that is largely funded through the 28-member European Union (EU). According to a report published in the Charcot-Marie-Tooth…
Continue ReadingA New European Consortium Dedicated to Finding and Treating Rare Diseases
Alzheimer’s disease (AD) is a neurodegenerative disease and the major cause of impaired memory affecting the older population. Reported cases are rapidly increasing. So far, clinical trials have failed…
The accelerated approval granted by the FDA for the Duchenne muscular dystrophy drug eteplirsen, developed by Sarepta Therapeutics, was granted only after internal disagreements and protests had been resolved.…
Continue ReadingFDA Approval Was Granted For a Duchenne Muscular Dystrophy Drug Amid Internal Disagreements
Fierce Biotech recently focused on a report by The BMJ, a British science journal, on the validity of clinical trials which are critical to decision making by patients and…
Continue ReadingBritish Science Journal Authors Voice Concerns Over Low Standards Supporting Cancer Drugs
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Sign Up For Our Patient Panel
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.